Literature DB >> 15708846

LGR8 signal activation by the relaxin-like factor.

Erika E Büllesbach1, Christian Schwabe.   

Abstract

The relaxin-like factor (RLF) is thought to be responsible for the intra-abdominal migration of the testis during mammalian development. Our latest studies of RLF and LGR8 have revealed that the N-terminal region of the A chain is not required for receptor binding but is indispensable for cyclic AMP generation. RLF derivatives with six residues deleted from the N terminus of the A chain are active, whereas further truncation, up to the first A chain cysteine (A-10), yields tightly binding ligands devoid of signaling activity. These derivatives are specific competitive inhibitors (RLFi) of RLF. Although receptor binding is dependent upon B chain residues, the N-terminal region of the A chain is a generic trigger of the trans-membrane signaling activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708846     DOI: 10.1074/jbc.M414443200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  The minimal active structure of human relaxin-2.

Authors:  Mohammed Akhter Hossain; K Johan Rosengren; Chrishan S Samuel; Fazel Shabanpoor; Linda J Chan; Ross A D Bathgate; John D Wade
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

Review 3.  Relaxin family peptides: structure-activity relationship studies.

Authors:  Nitin A Patil; K Johan Rosengren; Frances Separovic; John D Wade; Ross A D Bathgate; Mohammed Akhter Hossain
Journal:  Br J Pharmacol       Date:  2017-01-19       Impact factor: 8.739

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin.

Authors:  Linda J Chan; K Johan Rosengren; Sharon L Layfield; Ross A D Bathgate; Frances Separovic; Chrishan S Samuel; Mohammed A Hossain; John D Wade
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

6.  The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.

Authors:  Daniel J Scott; K Johan Rosengren; Ross A D Bathgate
Journal:  Mol Endocrinol       Date:  2012-09-12

7.  The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice.

Authors:  F P Yuan; X Li; J Lin; C Schwabe; E E Büllesbach; C V Rao; Z M Lei
Journal:  Reproduction       Date:  2010-02-12       Impact factor: 3.906

Review 8.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

9.  The structural determinants of insulin-like Peptide 3 activity.

Authors:  Ross A D Bathgate; Soude Zhang; Richard A Hughes; K Johan Rosengren; John D Wade
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-01       Impact factor: 5.555

Review 10.  In a Class of Their Own - RXFP1 and RXFP2 are Unique Members of the LGR Family.

Authors:  Emma J Petrie; Samantha Lagaida; Ashish Sethi; Ross A D Bathgate; Paul R Gooley
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.